← All Topics / ade

FDA ADE reports for Tildipirosin

ade_tildipirosin_adverse_events

ade en 2026-07-22

Tildipirosin — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Tildipirosin is a active ingredient.

Total reports

Tildipirosin: 196

Reports by species (top entries)

  • Cattle 161
  • Human 12
  • Other Deer 1
  • Pig 1

Top reported reactions (VEDDRA terms, top entries)

  • Lack of efficacy (bacteria) - NOS 118
  • DEATH-TREATMENT FAILURE 70
  • CULTURE/TITER DATA ABNORMAL 63
  • Death 60
  • PR-LUNG(S), LESION(S) 39
  • Vials, Damaged 16
  • Containers, Abnormal 13
  • Injection site swelling 12
  • Death by euthanasia 11
  • Respiratory tract disorder NOS 10

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b18.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

FDA ADE reports for Tildipirosin (active ingredient) — total reports, species & reaction breakdown
Source document: FDA FAERS / openFDA Animal & Veterinary Event Reports
US FDA Center for Veterinary Medicine (openFDA animal & veterinary event database)retrieved 2026-07-22

Verification file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b18.json

Link points to the issuing authority's site; a direct document link is still being verified.